Non-invasive Measurement of Neonatal Central and Peripheral Hemodynamics
NInHeDyNeo
1 other identifier
observational
163
1 country
1
Brief Summary
Non-invasively neonatal cardiac output can be measured by multiple methods, but the gold standard still remains conventional echocardiography. It is accurate, but needs a long training for new users to assess cardiac function. Continuous-wave Doppler ultrasound monitor USCOM is a relatively new monitor which can perform faster and less complex cardiac function measurement, also it is easier for the operator to get trained. The aim of the study is to assess the level of agreement between cardiac output measured with conventional echocardiography and with USCOM, to present normal ranges for neonates of different gestational age and to look for early signs of hemodynamic changes during sepsis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2017
CompletedFirst Submitted
Initial submission to the registry
November 18, 2019
CompletedFirst Posted
Study publicly available on registry
December 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedApril 21, 2021
September 1, 2020
3.1 years
November 18, 2019
April 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Weight measurement
weight in grams
1 minute
Height measurement
length in centimeters
1 minute
Chest and head circumference
Chest and head circumference in centimeters
1 minute
Blood pressure measurement
non- invasive arterial blood pressure measurement in mmHg
1 minute
Pulse rate measurement
pulse rate in beats per minute
1 minute
Near- Infrared Spectroscopy for regional blood flow
One sensor on the forehead, another- on the back to check for regional blood flow in the brain and kidney with Near- Infrared Spectroscopy
15-20 minutes
Echocardioscopy for left ventricular outflow tract diameter
Echocardiography for left ventricular outflow tract diameter in centimeters
2-3 minutes
Echocardioscopy to measure velocity time integral
Echocardiography to measure velocity time integral at the aortic valve in centimeters. After that the software of the device calculates cardiac output.
3 minutes
USCOM examination
USCOM 1A uses continuous wave Doppler for flow curves, which are obtained at the suprasternal notch for an optimal flow signal at the aortic valve. The software of the device calculates cardiac output then
3-5 minutes
Study Arms (3)
Healthy preterm neonate
Neonate 26 weeks to 36 weeks + 6 days of gestation, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections.
Healthy term neonate
Neonate from 37 weeks of gestation, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections.
Sick neonate
Neonate of any gestation, without congenital heart defects, with clinically and laboratory-identified infection.
Interventions
doplerometry with USCOM and echocardiograph is made for assessing central blood flow and spectroscopy with NONIN- for the blood flow in individual peripheral organs (brain and kidney)
Eligibility Criteria
The study enrolled both preterm and full-term newborns of any gestational age, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections in control group.
You may qualify if:
- newborns of any gestational age
- parental consent acquired
You may not qualify if:
- congenital malformations
- hemodynamic instability in control group
- any respiratory support in control group
- infection in control group
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vilnius University, Neonatology Centre
Vilnius, 08464, Lithuania
Related Publications (1)
Pliauckiene A, Liubsys A, Vankeviciene R, Usonis V. Ultrasonic cardiac output monitor provides effective non-invasive bedside measurements of neonatal cardiac output. J Clin Monit Comput. 2022 Jun;36(3):803-807. doi: 10.1007/s10877-021-00711-2. Epub 2021 Apr 30.
PMID: 33929641DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Vytautas Usonis, MD
Vilnius University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2019
First Posted
December 16, 2019
Study Start
September 12, 2017
Primary Completion
September 30, 2020
Study Completion
September 30, 2020
Last Updated
April 21, 2021
Record last verified: 2020-09